Tailored Anti-Inflammatory (A-I) Diet for Hispanics with Ulcerative Colitis (UC)

Description

The purpose of this study is to test the effect of an anti-inflammatory diet that incorporates native foods of the Hispanics/Latino (H/L) diet on disease remission in H/L patients with Ulcerative Colitis (UC) and to identify biomarkers of response to dietary therapy.

Conditions

Ulcerative Colitis

Study Overview

Study Details

Study overview

The purpose of this study is to test the effect of an anti-inflammatory diet that incorporates native foods of the Hispanics/Latino (H/L) diet on disease remission in H/L patients with Ulcerative Colitis (UC) and to identify biomarkers of response to dietary therapy.

A Culturally Tailored Anti-inflammatory Diet for Hispanic Patients with Ulcerative Colitis

Tailored Anti-Inflammatory (A-I) Diet for Hispanics with Ulcerative Colitis (UC)

Condition
Ulcerative Colitis
Intervention / Treatment

-

Contacts and Locations

Miami

University of Miami Health System, Miami, Florida, United States, 33136

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Documented diagnosis with ulcerative colitis from medical records.
  • * Self-Identify as Hispanic /Latino
  • * Ages 16-75
  • * SCCAI between 3-9 (no greater than 12 bowel movements a day)
  • * Fecal calprotectin \> 150mg/dl.
  • * On stable medications for their disease for the past 3 months
  • * Likeability of Latin foods (starchy vegetables, rice, tropical fruits, plantains)
  • * No recent Inflammatory Bowel Disease (IBD) related hospitalization in the last month.
  • * Diagnosis of Crohn's Disease (CD).
  • * Prior ileoanal anastomosis (J-pouch) or diversion
  • * No recent hospitalizations on the last 4 weeks
  • * No Clostridium difficile or enteric infections on the last 4 weeks
  • * No use of probiotics on the last 4 weeks
  • * Patients following the specific carbohydrate diet or mediterranean diet or anti-inflammatory diet
  • * No active cancer or conditions limiting their ability to follow a diet (heart failure, end stage renal disease)
  • * Pregnancy, breastfeeding or planning to become pregnant during study period
  • * Use of Total Parenteral Nutrition at the time of screening and during the study period
  • * Other significant or life-threatening co-morbidities
  • * The need for antibiotic use during the study period
  • * Adults unable to consent
  • * Ages less than 16 and \> 75 years old
  • * Prisoners

Ages Eligible for Study

16 Years to 75 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of Miami,

Oriana Damas, MD, MSCTI, PRINCIPAL_INVESTIGATOR, University of Miami Health System

Study Record Dates

2030-09-01